Global respiratory virus surveillance and vaccination

Public health monitoring and research efforts continue to address the impact of seasonal respiratory viruses, including influenza, COVID-19, and RSV.

In Italy, health officials are tracking COVID-19 variants such as XEC, Nimbus, and Stratus. While the situation is reported as stable, experts recommend hygiene measures and FFP2 masks in crowded areas to protect vulnerable populations. Concurrently, scientific research involving mice has provided insights into influenza immunity, suggesting that monocytes play a vital role in establishing long-term resident T-cell memory in the lungs.

In the Northeastern United States, health departments in New York are utilizing weekly dashboards to track case and hospitalization data for influenza, COVID-19, and RSV. In New Jersey, officials have noted concerns regarding influenza vaccination rates, which stood at approximately 60% in 2024, citing public hesitation driven by misconceptions about vaccine efficacy and manufacturing processes.